Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Purpose: Originally developed in English, the Oxford Depression Questionnaire (ODQ) is a patient-reported scale specifically developed for assessing emotional blunting in people with major depressive disorder (MDD). We aimed to examine the reliability and validity of the Japanese version of the ODQ. Patients and methods: This was a prespecified analysis of a prospective, 24-week, multicenter, observational cohort study of employed Japanese outpatients with MDD initiating treatment with vortioxetine according to the Japanese label (JRCT1031210200). Participants were assessed using the Japanese version of the ODQ and other clinical rating scales at baseline and Weeks 8, 12 and 24. Results: One hundred and sixteen patients initiated vortioxetine and had ≥1 post-baseline visit. Directionally, the associations between ODQ scores and other clinical measures were as expected and demonstrated good concurrent validity. Factor analysis shows that the scale has a good fit for three factors. The Cronbach's α coefficient was 0.912, and the scale also showed good test-retest reliability with intraclass correlation coefficients for the ODQ total score and domains ranging between 0.69 and 0.82. ODQ scores had strong positive correlations with symptom severity assessed using the Montgomery and Åsberg Depression Rating Scale and were moderately correlated with work productivity, overall functioning, and quality of life scales. Conclusion: Data from this prospective analysis confirm that the Japanese version of the ODQ retains the good validity and reliability of the original English scale and is suitable for use in prospective studies wanting to capture treatment effects on emotional blunting in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Cronbach’s alpha coefficient was 0.91, with good test–retest reliability (0.69 and 0.82).[11]”
From Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study (2026) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
The human emotional brain without sleep—a prefrontal amygdala disconnect
Yoo, S.-S., Gujar, N., Hu, P., Jolesz, F. A., & Walker, M. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.007 · Cited by 1,303 · cited 1×
“The significant correlation with sleep likely reflects the complex interplay between sleep and emotional regulation, 42,43 and there is evidence that insomnia reduces the intensity of emotions.”
BackgroundJaeger, J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000941 · Cited by 836
Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study
Price, J., Cole, V., & Goodwin, G. M. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051110 · Cited by 362
Emotional blunting with antidepressant treatments: A survey among depressed patients
Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.048 · Cited by 202 · cited 3×
“We found that four items ([6] concentration, [7] lassitude, [8] inability to feel, and [4] reduced sleep) reached statistical significance in the Spearman correlation with ODQ total scores, with the sum of these four individual MADRS “emotional blunting” scores showing a good correlation with ODQ…”
MethodResultDe Vaus, J., Hornsey, M. J., Kuppens, P., & Bastian, B. (2018) · Personality and Social Psychology Review · doi:10.1177/1088868317736222 · Cited by 190
Ishikawa, H., Kawakami, N., Kessler, R. C., & Collaborators, T. W. M. H. J. S. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000566 · Cited by 182
Cao, B., Zhu, J., Zuckerman, H., Rosenblat, J. D., Brietzke, E., Pan, Z., Subramanieapillai, M., Park, C., Lee, Y., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.002 · Cited by 175
Opbroek, A., Delgado, P. L., Laukes, C., McGahuey, C., Katsanis, J., Moreno, F. A., & Manber, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002870 · Cited by 147 · cited 3×
“We found that four items ([6] concentration, [7] lassitude, [8] inability to feel, and [4] reduced sleep) reached statistical significance in the Spearman correlation with ODQ total scores, with the sum of these four individual MADRS “emotional blunting” scores showing a good correlation with ODQ…”
BackgroundMethodResultInfluentialThe efficacy of vortioxetine on anhedonia in patients with major depressive disorder
Cao, B., Park, C., Subramaniapillai, M., Lee, Y., Iacobucci, M., Mansur, R. B., Zuckerman, H., Phan, L., & McIntyre, R. S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00017 · Cited by 139 · cited 2×
“Similar work in anhedonia has identified a MADRS anhedonia factor score, 37 which has proven useful in post-hoc analyses to explore the effects of treatment in studies that have included in MADRS as an indicator of overall depressive severity but have not included symptom-specific scales.”
BackgroundMethodFagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127
Self-citationSheehan, D. V., Harnett-Sheehan, K., Spann, M. E., Thompson, H. F., & Prakash, A. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328341bb5f · Cited by 124 · cited 1×
“36 Similarly, we observed a direct negative correlation of emotional blunting on ODQ with cognitive performance as assessed by DSST.”
MethodEmotional Expressiveness in Sleep-Deprived Healthy Adults
Minkel, J., Htaik, O., Banks, S., & Dinges, D. (2011) · Behavioral Sleep Medicine · doi:10.1080/15402002.2011.533987 · Cited by 111
A Brief Survey of Public Knowledge and Stigma Towards Depression
Yokoya, S., Maeno, T., Sakamoto, N., Goto, R., & Maeno, T. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3282w · Cited by 106
(2010) · PubMed Central · Cited by 101
Lam, R., Lamy, F.-X., Danchenko, N., Yarlas, A., White, M. K., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s175188 · Cited by 101
Altered Emotion Perception in Insomnia Disorder
Kyle, S. D., Beattie, L., Spiegelhalder, K., Rogers, Z., & Espie, C. A. (2014) · Sleep · doi:10.5665/sleep.3588 · Cited by 100
Rosenblat, J. D., Simon, G. E., Sachs, G. S., Deetz, I., Doederlein, A., DePeralta, D., Dean, M. M., & McIntyre, R. S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.027 · Cited by 92
McIntyre, R. S., Loft, H., & Christensen, M. C. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s296451 · Cited by 84 · cited 1×
“38,39 Just as there is a phenotypic overlap between emotional blunting and anhedonia, there is overlap between the 4 MADRS items identified as important for emotional blunting and those included in the MADRS anhedonia factor score.”
BackgroundSelf-citationPrice, J., Cole, V., Doll, H., & Goodwin, G. M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.030 · Cited by 81 · cited 1×
“9 Nevertheless, the results of this study indicate that the Japanese version of the ODQ retains the good validity and reliability of the original version.”
ResultFukuda, Y., & Hiyoshi, A. (2011) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-011-0212-3 · Cited by 74 · cited 1×
“45 Although we found that three factors explained 90% of the variance, our sample size was smaller than used to develop the original English version.”
MethodComparison of symptoms in Japanese and American depressed primary care patients
Waza, K. (1999) · Family Practice · doi:10.1093/fampra/16.5.528 · Cited by 64 · cited 3×
“We found that four items ([6] concentration, [7] lassitude, [8] inability to feel, and [4] reduced sleep) reached statistical significance in the Spearman correlation with ODQ total scores, with the sum of these four individual MADRS “emotional blunting” scores showing a good correlation with ODQ…”
MethodResultDisentangling fatigue from anhedonia: a scoping review
Billones, R. R., Kumar, S., & Saligan, L. N. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00960-w · Cited by 60 · cited 1×
“41 However, while multiple linear regression analysis also identified MADRS sleep item as relevant to emotional blunting, it did not pick up items of apparent and reported sadness that are included in the anhedonia factor score.”
BackgroundMcIntyre, R. S., Woldeyohannes, H. O., Soczynska, J. K., Maruschak, N. A., Wium-Andersen, I. K., Vinberg, M., Cha, D. S., Lee, Y., Xiao, H. X., Gallaugher, L. A., et al. (2016) · CNS Spectrums · doi:10.1017/s1092852915000747 · Cited by 56
Emotional blunting in patients with depression. Part I: clinical characteristics
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00387-1 · Cited by 53
Self-citationChristensen, M. C., Fagiolini, A., Florea, I., Loft, H., Cuomo, A., & Goodwin, G. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.099 · Cited by 52 · cited 1×
“As in the previous validation study reported by Christensen et al, 21 we observed a strong direct correlation of emotional blunting on the ODQ with depression severity as assessed by the MADRS, indicating that improvement in emotional blunting with vortioxetine treatment is likely reflected in…”
ResultSelf-citationAnhedonia and blunted affect in major depressive disorder
Loas, G., Salinas, E., Pierson, A., Guelfi, J. D., & Samuel-Lajeunesse, B. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90277-1 · Cited by 48
Evaluation of Emotional Adverse Effects of Antidepressants: A Follow-up Study
Aşçıbaşı, K., Çökmüş, F. P., Dikici, D. S., Özkan, H. M., Alçı, D., Altunsoy, N., Kuru, E., Yüzeren, S., & Aydemır, Ö. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001300 · Cited by 35
Neurobiology of emotions: an update
Esperidião-Antonio, V., Majeski-Colombo, M., Toledo-Monteverde, D., Moraes-Martins, G., Fernandes, J. J., Bauchiglioni de Assis, M., Montenegro, S., & Siqueira-Batista, R. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1285983 · Cited by 29
Christensen, M. C., Ren, H., & Fagiolini, A. M. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00392-4 · Cited by 21
Self-citationAdapting the Goal Attainment Approach for Major Depressive Disorder
McCue, M., Parikh, S. V., Mucha, L., Sarkey, S., Cao, C., Eramo, A., Opler, M. G. A., Webber-Lind, B., & François, C. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00151-w · Cited by 20
Mattingly, G. W., Necking, O., Schmidt, S. N., Reines, E. H., & Ren, H. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2178082 · Cited by 20 · cited 1×
“38,39 Just as there is a phenotypic overlap between emotional blunting and anhedonia, there is overlap between the 4 MADRS items identified as important for emotional blunting and those included in the MADRS anhedonia factor score.”
BackgroundPeters, E. M., Balbuena, L., & Lodhi, R. J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.066 · Cited by 13 · cited 1×
“13 Limitations of this analysis include the focus on employed patients with MDD when previous studies in Japan have suggested that people with higher socioeconomic status and full-time work may be reluctant to consult professionals and receive medical treatment.”
BackgroundReliability and validity of the Chinese version of the Oxford Depression Questionnaire (ODQ-Chinese)
Chen, J., Chen, W., Zhang, H., Hong, W., Zhang, L., Mi, W., Qin, J., & He, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.044 · Cited by 12
Zhu, Y., Wu, L., Ye, S., Fu, Y., Huang, H., Lai, J., Shi, C., & Hu, S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s396356 · Cited by 5
Demiya, S., Takeno, S., Kim, S., Lee, W., & Sakai, Y. (2022) · Value in Health · doi:10.1016/j.jval.2022.09.936 · Cited by 4
Watanabe, K., Moriguchi, Y., & Ren, H. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.1411 · Cited by 3
Self-citationWatanabe, K., Moriguchi, Y., Kato, M., Kikuchi, T., Moriguchi, Y., Christensen, M. C., & Touya, M. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.100796 · Cited by 3
Self-citation
Research works printed but not linked: 2
- Sansone, 2010, Psychiatry, 7, 14
- 1976, ECDEU Assessment Manual for Psychopharmacology
Cited by
Kikuchi, T., Iga, J., Hattori, A., Tokuda, F., Moriguchi, Y., & Hoshino, T. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s485109 · Cited by 3
“While previous studies have shown moderate to strong correlations between ODQ and social function scores, 16,20,27,28 there has been limited reporting on the relationships between the subdomains of EB and social functioning.”
InfluentialSelf-citationNazir, N., Nazir, D., Mehmood, R., Wani, Z. A., & Raj, R. (2026) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_201_25 · Cited by 2
“[11] Data were recorded in Microsoft Excel.”
Polish-language adaptation of the Oxford Depression Questionnaire (ODQ)
Cubała, W. J., Milska-Musa, K. A., Landowski, J., Wiglusz, M. S., Włodarczyk, A., Szarmach, J., Springer, J., & Słupski, J. (2025) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2024.0029 · Cited by 1
Ünsal, C., Yalım, E., Alpay, E. H., & Gündoğmuş, İ. (2026) · Psychiatric Quarterly · doi:10.1007/s11126-026-10304-4
Metadata
- Authors
- Kato, M., Kikuchi, T., Watanabe, K., Sumiyoshi, T., Moriguchi, Y., Åström, D., & Christensen, M.
- Affiliations
- Kansai Medical University (JP)
- Keio University (JP)
- Kyorin University (JP)
- National Center of Neurology and Psychiatry (JP)
- Lundbeck (Denmark) (DK)
- Corresponding author
- Moriguchi, Yoshiya
- ORCID
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2023-11
- Volume
- Volume 19
- Pages
- 2401-2412
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC10640815
- OpenAlex
- W4388495974
- Cited by
- 3
- References
- 42
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Cell Science Research Foundation
- Japan Research Foundation for Clinical Pharmacology
- Japanese Society of Clinical Neuropsychopharmacology
- Eisai
- Meiji Seika Pharma
- Astellas Pharma
- Shionogi
- Otsuka Pharmaceutical
- SENSHIN Medical Research Foundation
- Mitsubishi Tanabe Pharma Corporation
- Ono Pharmaceutical
- H. Lundbeck A/S
- Japan Society for the Promotion of Science
- Janssen Pharmaceuticals
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- Japanese version, major depressive disorder, emotional blunting, vortioxetine, patient-reported outcome measures, scale reliability, concurrent validity, factor structure, labor productivity, quality of life, outpatients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.